IMVAQ Therapeutics
Sammamish
About IMVAQ Therapeutics
Imvaq is a biotechnology firm developing novel immuno-oncologics to treat metastatic cancer. It focuses on developing therapeutic products that work in tandem with a patient's immune system to eradicate cancer locally and globally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $20.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2020)
- Website: imvaq.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/imvaq-therapeutics-96897 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.